In 60% of patients with SMARCA4‐dNSCLC, the lesions were located in the upper lobe of the lung, and 69% of the SMARCA4‐dNSCLC patients had peripheral lung cancer. This evidence concerns the gene SMARCA4 and lung carcinoma.